# Tiotropium

## Spiriva Respimat 2.5mcg/puff

| TAH Drug Code      | [ESPIR](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ESPIR){:target="_blank"}                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Maintenance treatment of patients with COPD (including chronic bronchitis & emphysema).                                                                                                                                                                                                 |
| Dosing             | Adult:Inhale 2 puffs once daily at the same time of day. Age 6-17 years with asthma: 2 puffs once daily at the same time of day. Age <6 years: Limited data available.                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                           |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                           |
| Contraindications  | Patients with a history of hypersensitivity to atropine or its derivatives eg, ipratropium or oxitropium, or to any component of Spiriva.                                                                                                                                               |
| Adverse Effects    | GI disturbances, cough & local irritation, dysuria, urinary retention (in men), tachycardia, allergic reactions. Gastrointestinal: Constipation (4% ), Xerostomia (12% to 16% ) Respiratory: Pharyngitis (7% to 9% ), Sinusitis (3% to 11% ), Upper respiratory infection (41% to 43% ) |
| Pregnancy          | No (Limited) Human Data â€“ Animal Data Suggest Low Risk                                                                                                                                                                                                                                  |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/tiotropium-drug-information){:target="_blank"}                                                                                                                                                                                             |

